These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 28617441

  • 1. Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells.
    Haydn T, Metzger E, Schuele R, Fulda S.
    Cell Death Dis; 2017 Jun 15; 8(6):e2879. PubMed ID: 28617441
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Critical role of mitochondria-mediated apoptosis for JNJ-26481585-induced antitumor activity in rhabdomyosarcoma.
    Heinicke U, Kupka J, Fichter I, Fulda S.
    Oncogene; 2016 Jul 14; 35(28):3729-41. PubMed ID: 26616861
    [Abstract] [Full Text] [Related]

  • 4. Co-targeting of BET proteins and HDACs as a novel approach to trigger apoptosis in rhabdomyosarcoma cells.
    Enßle JC, Boedicker C, Wanior M, Vogler M, Knapp S, Fulda S.
    Cancer Lett; 2018 Aug 01; 428():160-172. PubMed ID: 29709701
    [Abstract] [Full Text] [Related]

  • 5. BCL-2 selective inhibitor ABT-199 primes rhabdomyosarcoma cells to histone deacetylase inhibitor-induced apoptosis.
    Heinicke U, Haydn T, Kehr S, Vogler M, Fulda S.
    Oncogene; 2018 Sep 01; 37(39):5325-5339. PubMed ID: 29858601
    [Abstract] [Full Text] [Related]

  • 6. Chemosensitization of rhabdomyosarcoma cells by the histone deacetylase inhibitor SAHA.
    Heinicke U, Fulda S.
    Cancer Lett; 2014 Aug 28; 351(1):50-8. PubMed ID: 24814395
    [Abstract] [Full Text] [Related]

  • 7. The novel dual BET/HDAC inhibitor TW09 mediates cell death by mitochondrial apoptosis in rhabdomyosarcoma cells.
    Laszig S, Boedicker C, Weiser T, Knapp S, Fulda S.
    Cancer Lett; 2020 Aug 28; 486():46-57. PubMed ID: 32445837
    [Abstract] [Full Text] [Related]

  • 8. Co-inhibition of BET proteins and PI3Kα triggers mitochondrial apoptosis in rhabdomyosarcoma cells.
    Boedicker C, Hussong M, Grimm C, Dolgikh N, Meister MT, Enßle JC, Wanior M, Knapp S, Schweiger MR, Fulda S.
    Oncogene; 2020 May 28; 39(19):3837-3852. PubMed ID: 32161312
    [Abstract] [Full Text] [Related]

  • 9. Arsenic trioxide induces Noxa-dependent apoptosis in rhabdomyosarcoma cells and synergizes with antimicrotubule drugs.
    Meister MT, Boedicker C, Graab U, Hugle M, Hahn H, Klingebiel T, Fulda S.
    Cancer Lett; 2016 Oct 28; 381(2):287-95. PubMed ID: 27521572
    [Abstract] [Full Text] [Related]

  • 10. Vorinostat-induced apoptosis in mantle cell lymphoma is mediated by acetylation of proapoptotic BH3-only gene promoters.
    Xargay-Torrent S, López-Guerra M, Saborit-Villarroya I, Rosich L, Campo E, Roué G, Colomer D.
    Clin Cancer Res; 2011 Jun 15; 17(12):3956-68. PubMed ID: 21652541
    [Abstract] [Full Text] [Related]

  • 11. Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
    Vasilatos SN, Katz TA, Oesterreich S, Wan Y, Davidson NE, Huang Y.
    Carcinogenesis; 2013 Jun 15; 34(6):1196-207. PubMed ID: 23354309
    [Abstract] [Full Text] [Related]

  • 12. BCL-xL-selective BH3 mimetic sensitizes rhabdomyosarcoma cells to chemotherapeutics by activation of the mitochondrial pathway of apoptosis.
    Faqar-Uz-Zaman SF, Heinicke U, Meister MT, Vogler M, Fulda S.
    Cancer Lett; 2018 Jan 01; 412():131-142. PubMed ID: 28947136
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Concomitant targeting of Hedgehog signaling and MCL-1 synergistically induces cell death in Hedgehog-driven cancer cells.
    Meister MT, Boedicker C, Linder B, Kögel D, Klingebiel T, Fulda S.
    Cancer Lett; 2019 Nov 28; 465():1-11. PubMed ID: 31465840
    [Abstract] [Full Text] [Related]

  • 15. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
    Gillespie S, Borrow J, Zhang XD, Hersey P.
    Apoptosis; 2006 Dec 28; 11(12):2251-65. PubMed ID: 17051334
    [Abstract] [Full Text] [Related]

  • 16. Eribulin synergizes with Polo-like kinase 1 inhibitors to induce apoptosis in rhabdomyosarcoma.
    Stehle A, Hugle M, Fulda S.
    Cancer Lett; 2015 Aug 28; 365(1):37-46. PubMed ID: 25917079
    [Abstract] [Full Text] [Related]

  • 17. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
    Graab U, Hahn H, Fulda S.
    Oncotarget; 2015 Apr 20; 6(11):8722-35. PubMed ID: 25749378
    [Abstract] [Full Text] [Related]

  • 18. The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.
    Zhang XD, Gillespie SK, Borrow JM, Hersey P.
    Mol Cancer Ther; 2004 Apr 20; 3(4):425-35. PubMed ID: 15078986
    [Abstract] [Full Text] [Related]

  • 19. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
    Shankar S, Singh TR, Fandy TE, Luetrakul T, Ross DD, Srivastava RK.
    Int J Mol Med; 2005 Dec 20; 16(6):1125-38. PubMed ID: 16273296
    [Abstract] [Full Text] [Related]

  • 20. Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells.
    Erdogdu U, Dolgikh N, Laszig S, Särchen V, Meister MT, Wanior M, Knapp S, Boedicker C.
    Neoplasia; 2022 Feb 20; 24(2):109-119. PubMed ID: 34959030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.